What should be assessed regularly in patients using antidepressants like SSRIs and SNRIs?

Regular assessment for suicidal thoughts in patients using antidepressants like SSRIs and SNRIs is essential because these medications can affect mood and behavior. During the treatment process, especially when starting a new antidepressant or adjusting the dosage, patients may experience changes in their mood or may have an increase in suicidal ideation, particularly during the initial weeks of treatment or when doses are changed.

Monitoring for suicidality ensures that healthcare providers can timely intervene if a patient shows signs of worsening depression or suicidal thoughts. This is particularly important in younger populations, as studies have indicated a heightened risk of suicidal thoughts and behaviors in adolescents and young adults taking these medications. Regular assessment helps safeguard the patient’s mental health and provides an opportunity for timely support or adjustment of treatment if necessary.

The other options, while potentially important in different contexts, do not have the same level of critical importance in the routine monitoring of patients prescribed antidepressants.